ER-β, or Estrogen Receptor Beta, is one of the two main types of nuclear receptors for the hormone estrogen, functioning as a ligand-activated transcription factor that modulates gene expression. Unlike its counterpart, ER-α, ER-β is generally associated with anti-proliferative, anti-inflammatory, and neuroprotective effects. Its balanced activation is crucial for bone health, cardiovascular protection, and cognitive function in both sexes.
Origin
The discovery of ER-β in the mid-1990s fundamentally changed the understanding of estrogen’s diverse physiological roles, moving beyond the simple, singular mechanism previously attributed to ER-α. Its distinct tissue distribution and functional profile necessitated a clear nomenclature, which uses the Greek letter beta (β) to differentiate it from the alpha (α) receptor. This discovery paved the way for selective estrogen receptor modulators (SERMs).
Mechanism
Upon binding to its estrogen ligand, the ER-β receptor dimerizes and translocates to the nucleus, where it binds to specific DNA sequences known as Estrogen Response Elements (EREs) or interacts with other transcription factors. This binding modulates the rate of transcription of target genes. The unique functional outcome of ER-β activation, compared to ER-α, is largely determined by its distinct interactions with co-activator and co-repressor proteins in different cell types.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.